
United Therapeutics (UTHR)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy United Therapeutics (UTHR) Stock
Start investing in United Therapeutics (UTHR)
About United Therapeutics (UTHR)
Market cap | $12.78B |
Friday's volume | 564.44K |
Revenue (TTM) | $2.99B |
Avg. daily volume | 530.12K |
EBITDA (TTM) | $1.48B |
Open | $283.55 |
Price / earnings ratio | 11.31x |
Friday's range | $282 - $287.12 |
Debt / equity | 2.94x |
52 week range | $266.98 - $417.82 |
5 year debt / equity | 13.09x |
Beta (LTM) | 0.57x |
Interest coverage | 32.1x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 5.46x |
Ex-dividend date | — |
Next earnings | Jul 30, 2025 |
Dividend payable date | — |
United Therapeutics Stock Rating
United Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy UTHR stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in UTHR stock
Navigate to the Explore page. Then, type UTHR into the search bar. When you see UTHR stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased UTHR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
United Therapeutics Stock Earnings
The value each UTHR share was expected to gain vs. the value that each UTHR share actually gained.
United Therapeutics (UTHR) reported Q1 2025 earnings per share (EPS) of $6.63, beating estimates of $6.53 by 1.53%. In the same quarter last year, United Therapeutics's earnings per share (EPS) was $6.17. United Therapeutics is expected to release next earnings on 07/30/2025, with an earnings per share (EPS) estimate of $0.